Exploring the Role of Extracorporeal Photopheresis in Kidney Transplant Management [PDF]
Transplantation DirectExtracorporeal photopheresis (ECP) is emerging as an apoptotic cell-based therapy that suppresses alloimmunity, promotes donor-specific regulation, and reduces the need for conventional maintenance immunosuppression.
Michael Nicoli, MSc +2 more
doaj +4 more sources
Extracorporeal Photopheresis in Dermatological Diseases. [PDF]
Int J Mol SciExtracorporeal photopheresis (ECP) is an apheresis procedure that is conventionally used as a first-line treatment for cutaneous and leukemic subtypes of T-cell lymphoma, such as Sezary’s syndrome and mycosis fungoides. Over the past three decades, its immunotherapeutic properties have been tested on a variety of autoimmune conditions, including many ...
Terhaar H, Saleem M, Yusuf N.
europepmc +5 more sources
Extracorporeal photopheresis in stiff person syndrome [PDF]
Frontiers in ImmunologyYandy Marx Castillo-Aleman +1 more
doaj +4 more sources
Guidelines on the use of extracorporeal photopheresis [PDF]
, 2013 Peer ...
Robert Knobler +39 more
openalex +4 more sources
A survey of extracorporeal photopheresis treatment in pediatric patients in the United Kingdom [PDF]
eJHaem, 2020 Extracorporeal photopheresis (ECP) is a second‐line therapy in acute and chronic GVHD and solid organ transplant rejection. We report ECP use in 98 pediatric patients in seven UK centers from 2010 to 2017, the majority treated for aGVHD (73.5%).
Aisling M. Flinn +12 more
doaj +2 more sources
Extracorporeal Photopheresis—An Overview
Frontiers in Medicine, 2018 Extracorporeal photopheresis (ECP) has been in clinical use for over three decades after receiving FDA approval for the palliative treatment of the Sézary Syndrome variant of cutaneous T-cell lymphoma (CTCL) in 1988.
Ara Cho +2 more
doaj +3 more sources
Extracorporeal Photopheresis Stimulates Tissue Repair after Transplantation [PDF]
Transplantation DirectExtracorporeal photopheresis (ECP) is a safe and effective therapy with long-established indications in treating T cell–mediated immune diseases, including steroid refractory graft-versus-host disease and chronic rejection after heart or lung ...
Fabiola Arella, MSc +2 more
doaj +2 more sources
Extracorporeal Photopheresis versus Anticytokine Therapy as a Second-Line Treatment for Steroid-Refractory Acute GVHD: A Multicenter Comparative Analysis [PDF]
, 2013 The optimal therapy for steroid-refractory (SR) acute graft-versus-host disease (aGVHD) is undefined. We studied patients with SR aGVHD, comparing extracorporeal photopheresis (ECP; n = 57) and anticytokine therapy (n = 41). In multivariate analyses, ECP,
Madan Jagasia +11 more
openalex +2 more sources
Advances in extracorporeal photopheresis
Zhongguo shuxue zazhi, 2022 Extracorporeal photopheresis(ECP) is a bidirectional cellular immunomodulatory therapy based on leukapheresis, which can mediate not only immunopotentiation but also immunosuppression.
Zhanrui CHENG +3 more
doaj +2 more sources
Extracorporeal photopheresis as induction therapy in lung transplantation for cystic fibrosis: a pilot randomized trial [PDF]
Frontiers in ImmunologyIntroductionExtracorporeal photopheresis (ECP) is a viable treatment that slows the progression of chronic lung allograft dysfunction. Despite its immunoregulatory potential, data on extracorporeal photopheresis as an induction therapy remain rather ...
Ilaria Righi +19 more
doaj +2 more sources